Editas Medicine Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.51

-0.07 (-2.71%)

As of Sep 28, 10:16 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 12 67%

Hold 4 22%

Sell 2 11%

Price Target

Analyst Price Target +410.4% upside

Low Target $8.62

Average Target $12.81

High Target $14.59

Current Price $2.51

Current
$2.51

Target
$12.81

$8.62 $12.81 avg $14.59

Scenario Analysis

Bear Case

$8.62

243.4%

Low target

Base Case

$12.81

+410.4%

Avg target

Bull Case

$14.59

+481.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$4.54

-44.7% from high

52-Week Low

$1.66

+51.2% from low

Target vs 52W High

$12.81

+182.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%